Treatment of relapsed or refractory CLL

Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.

Previous
Previous

May 2025 Submission to the Health Select Committee on the Medicines Amendment Bill

Next
Next

Selection of initial therapy for symptomatic or advanced CLL